Operating since 1893, the Walter Reid Army Institute of Research (WRAIR) has been on the front line of protecting and enhancing Soldier readiness and lethality, particularly in the areas of brain health and infectious disease.

Travelan Shigellosis Challenge Completed

WRAIR, the Armed Forces Research Institute of Medical Science (an overseas WRAIR research directorate), and the Naval Medical Research Center partnered with Immuron to test Travelan against Shigella, Enterotoxigenic Escherichia coli, Vibrio cholerae and Campylobacter jejuni isolates. Travelan is a natural product marketed for the prevention of traveller’s diarrhoea. In a recent pre-clinical study, Travelan prevented the development of shigellosis in 75% of those receiving therapy.

Read WRAIR 2019 year in review here.